Osteoporosis in postmenopausal women.
作者信息
Moe Samantha, Paige Allison, Allan G Michael
机构信息
Clinical Evidence Expert at the College of Family Physicians of Canada (CFPC).
Medical Lead of Kildonan Medical Centre at Seven Oaks General Hospital in Winnipeg and Lecturer at the University of Manitoba.
出版信息
Can Fam Physician. 2021 May;67(5):346. doi: 10.46747/cfp.6705346.
Abstract
摘要
相似文献
1
Osteoporosis in postmenopausal women.绝经后女性的骨质疏松症
Can Fam Physician. 2021 May;67(5):346. doi: 10.46747/cfp.6705346.
2
Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.科威特最大省份的绝经后科威特女性居民中低骨量的流行情况。
Arch Osteoporos. 2012;7:147-53. doi: 10.1007/s11657-012-0092-1. Epub 2012 Sep 1.
3
[Prevalence of osteoporosis in postmenopausal women seen in family practice].[家庭医疗中绝经后女性骨质疏松症的患病率]
Ned Tijdschr Geneeskd. 1999 Feb 20;143(8):432-3.
4
[Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].[雌激素缺乏女性心血管疾病危险因素及骨密度状况的研究]
Zhonghua Fu Chan Ke Za Zhi. 2013 Oct;48(10):734-9.
5
The relationship between blood mercury level and osteoporosis in postmenopausal women.绝经后妇女血汞水平与骨质疏松症的关系。
Menopause. 2012 May;19(5):576-81. doi: 10.1097/gme.0b013e3182377294.
6
7
Evaluation of two tools for the early screening of osteoporosis in postmenopausal Chinese women with type 2 diabetes mellitus.两种工具用于绝经后2型糖尿病中国女性骨质疏松症早期筛查的评估
J Int Med Res. 2020 Mar;48(3):300060520903889. doi: 10.1177/0300060520903889.
8
The relationship among history of falls, osteoporosis, and fractures in postmenopausal women.绝经后女性跌倒史、骨质疏松症和骨折之间的关系。
Arch Phys Med Rehabil. 2002 Jul;83(7):903-6. doi: 10.1053/apmr.2002.33111.
9
Bone mineral density in postmenopausal Indian women with Colles fracture.患有Colles骨折的绝经后印度女性的骨密度
Natl Med J India. 2004 Jan-Feb;17(1):55-6.
10
Relationship between body composition and age, menopause and its effects on bone mineral density at segmental regions in Central Southern Chinese postmenopausal elderly women with and without osteoporosis.中国中南地区绝经后骨质疏松及非骨质疏松老年女性体成分与年龄、绝经及其对各部位骨密度的影响的关系。
Arch Gerontol Geriatr. 2011 Sep-Oct;53(2):e192-7. doi: 10.1016/j.archger.2010.09.002. Epub 2010 Sep 28.
本文引用的文献
1
Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.非典型股骨骨折风险与双膦酸盐预防脆性骨折。
N Engl J Med. 2020 Aug 20;383(8):743-753. doi: 10.1056/NEJMoa1916525.
2
Efficacy and Safety of Zoledronic Acid for Treatment of Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Controlled Trials.唑来膦酸治疗绝经后骨质疏松症的疗效和安全性：一项随机对照试验的荟萃分析。
Am J Ther. 2017 Sep/Oct;24(5):e544-e552. doi: 10.1097/MJT.0000000000000415.
3
Who should receive bone mineral density testing?谁应该接受骨密度检测？
Can Fam Physician. 2015 Jul;61(7):612.
4
Bisphosphonates: forever or 5 years and stop?双膦酸盐类药物：长期使用还是服用5年就停药？
Can Fam Physician. 2015 May;61(5):443.
5
Systematic review and meta-analysis of the efficacy and safety of alendronate and zoledronate for the treatment of postmenopausal osteoporosis.系统评价和荟萃分析阿仑膦酸钠和唑来膦酸治疗绝经后骨质疏松症的疗效和安全性。
Gynecol Endocrinol. 2013 Dec;29(12):1005-14. doi: 10.3109/09513590.2013.813468. Epub 2013 Sep 25.
6
Denosumab for prevention of fractures in postmenopausal women with osteoporosis.地诺单抗预防绝经后骨质疏松症女性骨折
N Engl J Med. 2009 Aug 20;361(8):756-65. doi: 10.1056/NEJMoa0809493. Epub 2009 Aug 11.
7
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.利塞膦酸盐用于绝经后妇女骨质疏松性骨折的一级和二级预防。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD004523. doi: 10.1002/14651858.CD004523.pub3.
8
Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.阿仑膦酸钠用于绝经后妇女骨质疏松性骨折的一级和二级预防。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD001155. doi: 10.1002/14651858.CD001155.pub2.
9
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.阿仑膦酸盐、依替膦酸盐、利塞膦酸盐、雷洛昔芬和特立帕肽用于预防和治疗绝经后骨质疏松症的系统评价与经济学评估
Health Technol Assess. 2005 Jun;9(22):1-160. doi: 10.3310/hta9220.
Zotero 插件